Inset Technologies Incorporated Selects Clinivation’s Approvals Solution

Innovator of implantable pump technology expands product registration with clinivation’s worldwide Approvals solution.

Natick, MA, November 30, 2007 – clinivation, Inc. announced today that InSet Technologies Incorporated has selected clinivation’s Approvals solution.”InSet is clearly an innovator of next-generation implantable drug pump technology for the treatment of chronic pain and other important diseases and conditions,” said Joseph Kozikowski, M.D., clinivation’s President and Chief Executive Officer. “We are delighted that InSet’s senior management has selected clinivation to help position its products for continued growth and expansion,” he continued.Clinivation’s Approvals Practice delivers regulatory expertise, development strategy, and an outstanding track record.

About InSet Technologies Incorporated

InSet Technologies Incorporated is a medical device company developing proprietary implantable pumps that are designed to deliver therapeutic drugs for the treatment of chronic diseases and conditions.

For more on InSet Technologies, please visit www.insetinc.com.

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.